Analysts aren't deterred though, including Citi 's Yigal Nochomovitz, who recently raised his price target on CRSPR from $82 ...

CRISPR-Cas9 removed an extra chromosome 21 from some Down syndrome cells in the lab. Learn what the 30.6% result means and ...

CRISPR Therapeutics (Nasdaq: CRSP) today announced that clinical data from the Phase 1b trial of CTX310 ®, its ...

CRISPR halves model-generation time and cuts costs by ~40%, while automation, aquatic models, genetic testing and cryobanking boost efficiency and client retention.Dublin, Oct. 07, 2026 (GLOBE ...

Pathology professor Patrick Hsu’s $250,000 prize will accelerate the development of new gene-editing tools and artificial ...

A new commentary in Discover Plants argues that genomics, CRISPR genome editing, and tissue culture must be integrated with ...

ZUG, Switzerland, BOSTON - CRISPR Therapeutics (Nasdaq: CRSP), announced that a poster presentation highlighting the Company's Phase 1 clinical data of its investigational CRISPR/Cas9 gene-edited ...

IntroductionCRISPR-Cas has fundamentally transformed the landscape of genetic manipulation in life sciences. This technology, which recognizes, cuts, and edits specific DNA sequences, is utilized in a ...

The genetic code is usually described as an orderly language, read one letter after another in precise three-letter units.

CRISPR Therapeutics (Nasdaq: CRSP), today announced that a poster presentation highlighting the Company’s Phase 1 clinical data of its investigational CRISPR/Cas9 gene-edited allogeneic CAR T cell ...

To develop gene therapy tools based on CRISPR-associated transposons (CASTs), it is essential to define how transposon ends are recognized and paired during transposition. Transposon 7 (Tn7)–like ...